EVI5 and non-small cell lung carcinoma: In addition, EVI5 was shown to activate downstream Smad3 signaling pathways by interacting with TGF-β receptors, We integrated these findings in a model showing the pivotal role of EVI5 in the regulation in NSCLC (Fig. 8).